Inventor · disambiguated record
Michael Koslowski
Also filed as: KOSLOWSKI MICHAEL
53 granted patents·28 pending applications·413 citations·filing 2003–2025
98Inventor score
Files withSAHIN UGUR26GANYMED PHARMACEUTICALS AG24BIONTECH AG13GANYMED PHARMACEUTICALS GMBH7GAMMADELTA THERAPEUTICS LTD4
Top patents by PatentIndex Score
81 records- 0198US7527933B2Genetic products differentially expressed in tumors and the use thereofGANYMED PHARMACEUTICALS AG·Filed 2003·Granted May 5, 2009·115 cites·5 claims
- 0295US8946388B2Monoclonal antibodies for treatment of cancerSAHIN UGUR·Filed 2009·Granted Feb 3, 2015·41 cites·16 claims
- 0394US10738355B2Individualized vaccines for cancerSAHIN UGUR·Filed 2012·Granted Aug 11, 2020·41 cites·25 claims
- 0494US8637012B2Genetic products differentially expressed in tumors and the use thereofSAHIN UGUR·Filed 2011·Granted Jan 28, 2014·18 cites·9 claims
- 0594US8586047B2Genetic products differentially expressed in tumors and the use thereofSAHIN UGUR·Filed 2009·Granted Nov 19, 2013·20 cites·18 claims
- 0694US8088588B2Genetic products differentially expressed in tumors and the use of thereofSAHIN UGUR·Filed 2008·Granted Jan 3, 2012·17 cites·13 claims
- 0793US11859008B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS GMBH·Filed 2020·Granted Jan 2, 2024·2 cites·12 claims
- 0893US9718886B2Cancer therapy using CLDN6 target-directed antibodies in vivoSAHIN UGUR·Filed 2011·Granted Aug 1, 2017·13 cites·6 claims
- 0992US9487584B2Antibodies specific for claudin 6 (CLDN6)SAHIN UGUR·Filed 2010·Granted Nov 8, 2016·19 cites·20 claims
- 1092US9321842B2Antibodies for treatment of cancerSAHIN UGUR·Filed 2012·Granted Apr 26, 2016·14 cites·30 claims
- 1191US11248264B2Individualized vaccines for cancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GGMBH·Filed 2020·Granted Feb 15, 2022·5 cites·19 claims
- 1291US9175088B2Identification of tumor-associated markers for diagnosing or monitoring ovarian cancerSAHIN UGUR·Filed 2010·Granted Nov 3, 2015·8 cites·14 claims
- 1391US7785801B2Identification of surface-associated antigens for tumor diagnosis and therapyGANYMED PHARMACEUTICALS AG·Filed 2005·Granted Aug 31, 2010·14 cites·4 claims
- 1490US10233253B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS AG·Filed 2016·Granted Mar 19, 2019·7 cites·16 claims
- 1590US9044382B2Genetic products differentially expressed in tumors and the use thereofTüreci Özlem·Filed 2005·Granted Jun 2, 2015·17 cites·7 claims
- 1687US9533043B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Jan 3, 2017·7 cites·5 claims
- 1786US9216218B2Monoclonal antibodies for treatment of cancerSAHIN UGUR·Filed 2011·Granted Dec 22, 2015·11 cites·6 claims
- 1886US9194004B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Nov 24, 2015·6 cites·4 claims
- 1986US9090940B2Identification of surface-associated antigens for tumor diagnosis and therapySAHIN UGUR·Filed 2006·Granted Jul 28, 2015·3 cites·11 claims
- 2085US9775785B2Antibody to genetic products differentially expressed in tumors and the use thereofGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Oct 3, 2017·5 cites·12 claims
- 2185US8975375B2Identification of tumor-associated antigens for diagnosis and therapySAHIN UGUR·Filed 2011·Granted Mar 10, 2015·5 cites·15 claims
- 2285US2024092896A1Antibodies specific for claudin 6 (cldn6)GANYMED PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 2384US11473085B2Methods and compositions for diagnosis and treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2019·Granted Oct 18, 2022·1 cites·10 claims
- 2484US10724103B2Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapyBIONTECH AG·Filed 2017·Granted Jul 28, 2020·1 cites·3 claims
- 2584US9475867B2Monoclonal antibodies for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Oct 25, 2016·3 cites·18 claims
- 2684US8354104B2Monoclonal antibodies for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2008·Granted Jan 15, 2013·3 cites·5 claims
- 2784US2024101703A1Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 2883US2024084033A1Cancer therapy using cldn6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS GMBH·Filed 2023·Application pending·0 cites
- 2980US9255131B2Identification of surface-associated antigens for tumor diagnosis and therapyTüreci Özlem·Filed 2010·Granted Feb 9, 2016·4 cites·11 claims
- 3080US8961980B2Monoclonal antibodies for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2012·Granted Feb 24, 2015·5 cites·23 claims
- 3177US10253373B2Identification of tumor-associated markers for diagnosis and therapyBIONTECH AG·Filed 2017·Granted Apr 9, 2019·1 cites·5 claims
- 3277US9902778B2Cancer therapy using CLDN6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS AG·Filed 2016·Granted Feb 27, 2018·1 cites·19 claims
- 3377US9637548B2Methods and compositions for diagnosis and treatment of cancerSAHIN UGUR·Filed 2010·Granted May 2, 2017·2 cites·5 claims
- 3477US2023193261A1Methods and compositions for diagnosis and treatment of cancerGANYMED PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 3575US9932401B2Antibodies specific for claudin 6 (CLDN6)GANYMED PHARMACEUTICALS AG·Filed 2016·Granted Apr 3, 2018·1 cites·19 claims
- 3673US2022282322A1Individualized vaccines for cancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GG·Filed 2022·Application pending·0 cites
- 3773US2021145700A1Genetic products differentially expressed in tumors and the use thereofASTELLAS PHARMA INC·Filed 2020·Application pending·0 cites
- 3871US11858988B2Antibodies specific for claudin 6 (CLDN6)GANYMED PHARMACEUTICALS GMBH·Filed 2020·Granted Jan 2, 2024·0 cites·24 claims
- 3970US7429461B2Genetic products differentially expressed in tumors and use thereofGANYMED PHARMACEUTICALS AG·Filed 2003·Granted Sep 30, 2008·2 cites·7 claims
- 4069US2021079113A1Cancer therapy using cldn6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 4168US10919974B2Antibodies for treatment of cancer expressing claudin 6GANYMED PHARMACEUTICALS AG·Filed 2018·Granted Feb 16, 2021·0 cites·12 claims
- 4268US8716455B2Genetic products differentially expressed in tumors and use thereofSAHIN UGUR·Filed 2008·Granted May 6, 2014·0 cites·15 claims
- 4367US2024082308A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 4466US10745477B2Antibodies specific for claudin 6 (CLDN6)GANYMED PHARMACEUTICALS AG·Filed 2018·Granted Aug 18, 2020·0 cites·19 claims
- 4566US9453260B2Genetic products differentially expressed in tumors and use thereofGANYMED PHARMACEUTICALS AG·Filed 2014·Granted Sep 27, 2016·0 cites·8 claims
- 4665US10414824B2Genetic products differentially expressed in tumors and the use thereofGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Sep 17, 2019·0 cites·11 claims
- 4765US10302647B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2016·Granted May 28, 2019·0 cites·8 claims
- 4865US2014134165A1Identification of Tumor-Associated Markers for Diagnosis and TherapySAHIN UGUR·Filed 2014·Application pending·0 cites
- 4964US10844133B2Cancer therapy using CLDN6 target-directed antibodies in vivoGANYMED PHARMACEUTICALS AG·Filed 2018·Granted Nov 24, 2020·0 cites·20 claims
- 5064US10125196B2Monoclonal antibodies for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2016·Granted Nov 13, 2018·0 cites·12 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Koslowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →